|
|
Martek Biosciences Corporation - Comparative Business Analysis Snapshot
Business Description
Martek Biosciences Corporation. The Group's principal activity is to develop, manufacture and sell naturally produced products derived from microalgae, fungi and other microbes. The products and services include specialty, nutritional oils for infant formula, nutritional supplements and food ingredients to promote mental and cardiovascular health. The Group also develops new fluorescent detection products from microalgae that connect fluorescent algal proteins to antibodies. The trademarks of the Group include Neuromins (r), DHA Gold (r), DHASCO (r) and ARASCO (r). The Group operates in the United States, Europe and China.
Competitor Analysis
This analysis compares Martek Biosciences Corporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
